These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2960960)

  • 21. Effect of antiandrogens on some key enzymes of glycolysis in epididymis and ventral prostate of rat.
    Gupta G; Srivastava A; Setty BS
    Indian J Exp Biol; 1989 Apr; 27(4):324-8. PubMed ID: 2530166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a new topically active antiandrogen (RU 38882) on the rat sebaceous gland: comparison with cyproterone acetate.
    Bouton MM; Lecaque D; Secchi J; Tournemine C
    J Invest Dermatol; 1986 Feb; 86(2):163-7. PubMed ID: 2943819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of castration and antiandrogenic treatment on the sensitivity of rat seminal vesicle to sympathomimetic drugs.
    Porto CS; Abreu LC
    Braz J Med Biol Res; 1987; 20(5):603-5. PubMed ID: 2968126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
    Stárka L; Hampl R; Kasal A; Kohout L
    J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH).
    Geller J; Albert J
    Urol Res; 1987; 15(3):151-3. PubMed ID: 3629749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the mechanism of action of medrogestone and cyproterone acetate.
    Sufrin G; Coffey DS
    Invest Urol; 1975 Jul; 13(1):1-9. PubMed ID: 1140913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
    Furr BJ
    Prog Clin Biol Res; 1988; 260():13-26. PubMed ID: 2966405
    [No Abstract]   [Full Text] [Related]  

  • 28. Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate.
    Marchetti B; Poulin R; Plante M; Labrie F
    J Steroid Biochem; 1988 Oct; 31(4A):411-9. PubMed ID: 2845194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.
    Sogani PC; Whitmore WF
    Cancer Treat Res; 1988; 39():131-45. PubMed ID: 2908604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiandrogenic properties of nomegestrol acetate.
    Duc I; Botella J; Bonnet P; Fraboul F; Delansorne R; Paris J
    Arzneimittelforschung; 1995 Jan; 45(1):70-4. PubMed ID: 7893274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyproterone acetate: I. Microquantity releasing device of cyproterone acetate and its failure in inducing functional sterility in male rats.
    Chatterjee A; Ray P; Gupta M; Pal AK; Kolay AR
    Andrologia; 1977; 9(1):70-3. PubMed ID: 855942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of androgen and estrogen effects in guinea pig seminal vesicle epithelium and fibromuscular stroma by keoxifene (LY156758).
    Neubauer BL; Biser P; Jones CD; Mariotti A; Hoover DM; Thornton T; Thornton MO; Goode RL
    Prostate; 1989; 15(3):273-86. PubMed ID: 2531383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes.
    Werner S; Kunz S; Beckurts T; Heidecke CD; Wolff T; Schwarz LR
    Mutat Res; 1997 Dec; 395(2-3):179-87. PubMed ID: 9465929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity.
    Yamada T; Kunimatsu T; Sako H; Yabushita S; Sukata T; Okuno Y; Matsuo M
    Toxicol Sci; 2000 Feb; 53(2):289-96. PubMed ID: 10696777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
    Furr BJ; Tucker H
    Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal androgen blockade in relapsed prostate cancer.
    Geller J; Albert JD
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1127-31. PubMed ID: 2934257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity.
    Luo S; Martel C; Chen C; Labrie C; Candas B; Singh SM; Labrie F
    Urology; 1997 Dec; 50(6):913-9. PubMed ID: 9426723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of androstenedione-induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione (1-methyl-ADD).
    Habenicht UF; el Etreby MF
    Prostate; 1989; 14(4):309-22. PubMed ID: 2473459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver.
    Topinka J; Binkova B; Zhu HK; Andrae U; Neumann I; Schwarz LR; Werner S; Wolff T
    Carcinogenesis; 1995 Jul; 16(7):1483-7. PubMed ID: 7542174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.